Related Experiment Videos
A membrane-specific tyrosinase chelate: the mitotic regulator?
Abstract:
Cancer's random, reversible, unstable transitions to "normal" structures imply their functional relation. Similar random, continuous, reversible oncogene "mutational transformation" also lacks a consistent hybrid. Positing cancer's "mutationally altered genotype" leads to medically foreign causes, qualities, inducers, suppressors, immune proteins, and viruses. Its random variation, however, opposes the functionally discrete, ordered, stable, irreversible hybrid variation and single-valued transforms of molecular genetics. There, "causal mutational operators" remain unspecified; only consistent single-valued DNA base and amino acid change, as "transform operand", are made explicit. A mitotically "blocked" (normal) and "unblocked" (malignant) stem cell "phenotype", operationally constructed from microscopic data, is therefore viewed within the homeostatic context of open-system enzyme-regulatory equilibrium. This functional, stochastic field distribution between "structurally bound" and "freely dividing" stem cell number discloses their putative regulatory mitotic-blocking factor. A tyrosinase complex, interacting by Cu2+-Fe2+ chelation with a proline hydroxylase divisional enzyme near stem cell ribosomes, maintains steady-state mitotic equilibrium. Based upon familiar medical, biochemical, and energy principles this confronts cancer's pigmentary-depigmentary signs, glycolytic metabolism, elevated serum tyrosinase, defective collagen production, exposed membrane binding sites, and tyrosine's recent growth control role.
Insights
Cancer involves unstable cell transitions, challenging traditional mutation theories. This study proposes a novel enzyme-regulatory model for stem cell division, linking tyrosinase to cancer's progression.
Area of Science:
- Biochemistry
- Cell Biology
- Oncology
Background:
- Cancer is often viewed as resulting from random genetic mutations.
- Existing models struggle to explain the reversible and unstable nature of cancerous transformations.
- The precise mechanisms regulating stem cell division and their disruption in cancer remain incompletely understood.
Purpose of the Study:
- To investigate the functional relationship between normal and cancerous cell states.
- To explore an alternative model for cancer development based on enzyme regulation and stem cell phenotypes.
- To identify key molecular players involved in maintaining mitotic equilibrium.
Main Methods:
- Operational construction of normal (mitotically blocked) and malignant (unblocked) stem cell phenotypes from microscopic data.
- Analysis within the framework of open-system enzyme-regulatory equilibrium.
- Investigation of the role of a tyrosinase complex and proline hydroxylase in mitotic regulation.
Main Results:
- Cancer's transitions are proposed as functionally related, not solely random mutations.
- A stochastic field distribution between bound and dividing stem cells suggests a regulatory factor.
- A tyrosinase complex interacting with proline hydroxylase near ribosomes appears crucial for mitotic equilibrium.
Conclusions:
- The study challenges purely genetic models of cancer, proposing a functional, regulatory perspective.
- Tyrosinase activity, linked to pigmentary changes and collagen defects, is implicated in cancer's altered metabolism and growth.
- This homeostatic model offers new insights into cancer's complex etiology and potential therapeutic targets.